The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
The role of annexins in tumour development and progression
Abstract
The annexins are a super‐family of closely related calcium and membrane‐binding proteins. They have a diverse range of cellular functions that include vesicle trafficking, cell division, apoptosis, calcium signalling and growth regulation. Many studies have shown the annexins to be among the genes whose expression are consistently differentially altered in neoplasia. Some annexins show increased expression in specific types of tumours, while others show loss of expression. Mechanistic studies relating the changes in annexin expression to tumour cell function, particularly tumour invasion and metastasis, angiogenesis and drug resistance, are now also emerging. Changes in the expression of individual annexins are associated with particular types of tumour and hence the annexins may also be useful biomarkers in the clinic. Copyright © 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Annexins: From Structure to Function
Gerke, V., & Moss, S. E. (2002) · Physiological Reviews · doi:10.1152/physrev.00030.2001 · Cited by 2,029
Annexins: linking Ca2+ signalling to membrane dynamics
Gerke, V., Creutz, C. E., & Moss, S. E. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1661 · Cited by 1,410
Annexins – unique membrane binding proteins with diverse functions
Rescher, U., & Gerke, V. (2004) · Journal of Cell Science · doi:10.1242/jcs.01245 · Cited by 594
Oh, P., Li, Y., Yu, J., Durr, E., Krasinska, K. M., Carver, L. A., Testa, J. E., & Schnitzer, J. E. (2004) · Nature · doi:10.1038/nature02580 · Cited by 475
Annexin 1: the new face of an old molecule
Lim, L. H. K., & Pervaiz, S. (2007) · The FASEB Journal · doi:10.1096/fj.06-7464rev · Cited by 399
Falini, B., Tiacci, E., Liso, A., Basso, K., Sabattini, E., Pacini, R., Foa, R., Pulsoni, A., Favera, R. D., & Pileri, S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16356-3 · Cited by 244
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma.
Paweletz, C. P., Ornstein, D. K., Roth, M. J., Bichsel, V. E., Gillespie, J. W., Calvert, V. S., Vocke, C. D., Hewitt, S. M., Duray, P. H., Herring, J., et al. (2000) · PubMed · Cited by 226
Characterisation and protein expression profiling of annexins in colorectal cancer
Duncan, R., Carpenter, B., Main, L. C., Telfer, C., & Murray, G. I. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604128 · Cited by 210
Self-citationCell surface complex of cathepsin B/annexin II tetramer in malignant progression
Mai, J., Waisman, D. M., & Sloane, B. F. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00274-5 · Cited by 199
Dysregulation of the Annexin Family Protein Family Is Associated with Prostate Cancer Progression
Xin, W., Rhodes, D. R., Ingold, C., Chinnaiyan, A. M., & Rubin, M. A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63816-3 · Cited by 167
Overexpression of annexin 1 in pancreatic cancer and its clinical significance
Bai, X.-F. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i10.1466 · Cited by 164
Annexin II overexpression correlates with stromal tenascin-C overexpression
Emoto, K., Yamada, Y., SAWADA, H., FUJIMOTO, H., Ueno, M., Takayama, T., Kamada, K., 内藤, 彰., Hirao, S., & Nakajima, Y. (2001) · Cancer · Cited by 157
Tenascin C and annexin II expression in the process of pancreatic carcinogenesis
Esposito, I., Penzel, R., Chaib-Harrireche, M., Barcena, U., Bergmann, F., Riedl, S., Kayed, H., Giese, N. A., Kleeff, J. H., Frieß, H., et al. (2006) · The Journal of Pathology · doi:10.1002/path.1935 · Cited by 156
Karanjawala, Z. E., Illei, P. B., Ashfaq, R., Infante, J. R., Murphy, K. M., Pandey, A., Schulick, R. D., Winter, J., Sharma, R. B., Maitra, A., et al. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31815701f3 · Cited by 150
Hayes, M. J., & Moss, S. E. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.124 · Cited by 145
Garcia-Pedrero, J. M., Fernández, M. P., Morgan, R. O., Zapatero, A. H., González, M. V., Nieto, C. S., & Rodrigo, J. P. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63098-2 · Cited by 144
Annexin I Regulates SKCO-15 Cell Invasion by Signaling through Formyl Peptide Receptors
Babbin, B. A., Lee, W. Y., Parkos, C. A., Winfree, L. M., Akyildiz, A., Perretti, M., & Nusrat, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513025200 · Cited by 141
Annexin A3 is a potential angiogenic mediator
Park, J. E., Lee, D. H., Lee, J. A., Park, S. G., Kim, N.-S., Park, B. C., & Cho, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.004 · Cited by 136
ANX7, a candidate tumor suppressor gene for prostate cancer
Srivastava, M., Bubendorf, L., Srikantan, V., Fossom, L. H., Nolan, L., Glasman, M., Leighton, X., Fehrle, W., Pittaluga, S., Raffeld, M. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071055798 · Cited by 135
Liu, J.-W., Shen, J.-J., Tanzillo-Swarts, A., Bhatia, B., Maldonado, C. M., Person, M. D., Lau, S. S., & Tang, D. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206196 · Cited by 134
Rosengarth, A., Gerke, V., & Luecke, H. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4423 · Cited by 131
Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma.
Emoto, K., SAWADA, H., Yamada, Y., FUJIMOTO, H., Takahama, Y., Ueno, M., Takayama, T., Uchida, H., Kamada, K., 内藤, 彰., et al. (2001) · PubMed · Cited by 130
Diaz, V. M., Hurtado, M., Thomson, T. M., et al. (2004) · Gut · doi:10.1136/gut.2003.026831 · Cited by 124
Shen, D., Nooraie, F., Elshimali, Y., Lonsberry, V., He, J., Bose, S., Chia, D., Seligson, D. B., Chang, H. R., & Goodglick, L. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.06.001 · Cited by 116
Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer
Köllermann, J. W., Schlomm, T., Bang, H., et al. (2008) · European Urology · doi:10.1016/j.eururo.2008.01.001 · Cited by 111
Annexin 11 is required for midbody formation and completion of the terminal phase of cytokinesis
Tomás, A., Futter, C. E., & Moss, S. E. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200311054 · Cited by 104
Modulation of paclitaxel resistance by annexin IV in human cancer cell lines
Han, E. K.-H., Tahir, S. K., Cherian, S. P., Collins, N., & Ng, S.-C. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1311 · Cited by 97
Annexin A6 stimulates the membrane recruitment of p120GAP to modulate Ras and Raf-1 activity
Grewal, T., Evans, R., Rentero, C., Tebar, F., Cubells, L., de Diego, I., Kirchhoff, M. F., Hughes, W. E., Heeren, J., Rye, K., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208743 · Cited by 91
Srivastava, M., Montagna, C., Leighton, X., Glasman, M., Naga, S., Eidelman, O., Ried, T., & Pollard, H. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235927100 · Cited by 81
Herr, C., Smyth, N. R., Ullrich, S., Fan, Y., Sasse, P., Hescheler, J., Fleischmann, B. K., Lasek, K., Brixius, K., Schwinger, R. H. G., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4119-4128.2001 · Cited by 80
Corsten, M. F., Hofstra, L., Narula, J., & Reutelingsperger, C. P. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3000 · Cited by 76
Annexin-I expression modulates drug resistance in tumor cells
Wang, Y., Serfass, L., Roy, M., Wong, J., Bonneau, A.-M., & Georges, E. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.117 · Cited by 73
Francia, G., Mitchell, S., Moss, S. E., Hanby, A. M., Marshall, J. F., & Hart, I. (1996) · PubMed · Cited by 68
Calcium- and Cell Cycle-dependent Association of Annexin 11 with the Nuclear Envelope
Tomás, A., & Moss, S. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212669200 · Cited by 67
Hsiang, C., Tunoda, T., Whang, Y. E., Tyson, D. R., & Ornstein, D. K. (2006) · The Prostate · doi:10.1002/pros.20457 · Cited by 66
Zimmermann, U., Woenckhaus, C., Pietschmann, S., Junker, H., Maile, S., Schultz, K., Protzel, C., & Giebel, J. (2004) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-004-1103-4 · Cited by 61
Annexin 1: Differential expression in tumor and mast cells in human larynx cancer
Silistino‐Souza, R., Rodrigues‐Lisoni, F. C., Cury, P. M., Maniglia, J. V., Raposo, L. S., Tajara, E. H., Christian, H., & Oliani, S. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22639 · Cited by 59
Woźny, W., Schroer, K., Schwall, G., Poznanović, S., Stegmann, W., Dietz, K., Rogatsch, H., Schaefer, G., Huebl, H., Klocker, H., et al. (2007) · PROTEOMICS · doi:10.1002/pmic.200600646 · Cited by 59
Proteomics-based Validation of Genomic Data
Madoz‐Gúrpide, J., López-Serra, P., Martinez-Torrecuadrada, J. L., Sánchez, L., Lombardía, L., & Casal, J. I. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600048-mcp200 · Cited by 59
Molecular mechanisms involved in Ras inactivation: the annexin A6–p120GAP complex
Grewal, T., & Enrich, C. (2006) · BioEssays · doi:10.1002/bies.20503 · Cited by 57
Stein, T., Price, K. N., Morris, J. S., Heath, V. J., Ferrier, R. K., Bell, A. K., Pringle, M. A., Villadsen, R., Petersen, O. W., Sauter, G., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0547 · Cited by 57
ANXA7 expression represents hormone‐relevant tumor suppression in different cancers
Srivastava, M., Torosyan, Y., Raffeld, M. A., Eidelman, O., Pollard, H. B., & Bubendorf, L. (2007) · International Journal of Cancer · doi:10.1002/ijc.23008 · Cited by 55
Sharma, M. R., Rothman, V. L., Tuszynski, G. P., & Sharma, M. C. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.03.002 · Cited by 54
Annexin 2 expression is reduced in human osteosarcoma metastases
Gillette, J. M., Chan, D. C. F., & Nielsen‐Preiss, S. M. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20117 · Cited by 54
Annexin VI has tumour-suppressor activity in human A431 squamous epithelial carcinoma cells
Theobald, J., Hanby, A. M., Patel, K., & Moss, S. E. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.152 · Cited by 52
Hayes, M. J., Longbottom, R. E., EVANS, M. A., & Moss, S. E. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6191-2_1 · Cited by 51
Yee, D. S., Narula, N., Ramzy, I., Boker, J. R., Ahlering, T. E., Skarecky, D. W., & Ornstein, D. K. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-902-raipei · Cited by 48
Song, J., Shih, I., Salani, R., Chan, D. W., & Zhang, Z. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0569 · Cited by 43
Turnay, J., Lecona, E., Fernández‐Lizarbe, S., Guzmán‐Aránguez, A., Fernández, M. P., Olmo, N., & Lizarbe, M. A. (2005) · Biochemical Journal · doi:10.1042/bj20041918 · Cited by 42
Inhibition of H-Ras and MAPK is compensated by PKC-dependent pathways in annexin A6 expressing cells
Rentero, C., Evans, R., Wood, P., Tebar, F., de Muga, S. V., Cubells, L., de Diego, I., Hayes, T. E., Hughes, W. E., Pol, A., et al. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.08.008 · Cited by 36
ANX7 as a Bio‐Marker in Prostate and Breast Cancer Progression
Srivastava, M., Bubendorf, L., Nolan, L., Glasman, M., Leighton, X., Miller, G., Fehrle, W., Raffeld, M. A., Eidelman, O., Kallioniemi, O., et al. (2001) · Disease Markers · doi:10.1155/2001/239602 · Cited by 34
Goebeler, V., Ruhe, D., Gerke, V., & Rescher, U. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00634-3 · Cited by 29
Stewart, J. M., Fleshner, N. E., Cole, H. A., et al. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.040808 · Cited by 29
Activation of Raf‐1 is defective in annexin 6 overexpressing Chinese hamster ovary cells
Pons, M., Tebar, F., Kirchhoff, M., Peiró, S., de Diego, I., Grewal, T., & Enrich, C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02635-7 · Cited by 23
Hastie, C., Masters, J. R., Moss, S. E., & Naaby‐Hansen, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800189200 · Cited by 21
Cited by
Plasma membrane integrity in health and disease: significance and therapeutic potential
Dias, C., & Nylandsted, J. (2021) · Cell Discovery · doi:10.1038/s41421-020-00233-2 · Cited by 278
Bronisz, A., Wang, Y., Nowicki, M. O., Peruzzi, P., Ansari, K. I., Ogawa, D., Balaj, L., De Rienzo, G., Mineo, M., Nakano, I., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2650 · Cited by 222
Metadata
- Authors
- Mussunoor, S., & Murray, G.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2008-08-13
- Volume
- 216
- Issue
- 2
- Pages
- 131-140
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2026462337
- Cited by
- 299
- References
- 55
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.